Brief: Oasmia Says Finds Novel Candidate For Use In XR-18 Platform
24/01/2022 06:01
Jan 24 (Reuters) - Oasmia Pharmaceutical AB OASM.ST :
* OASMIA ANNOUNCES PROGRESS ON THE DEVELOPMENT OF ITS NEXT
GENERATION XR-18 DRUG DELIVERY TECHNOLOGY
* HAS IDENTIFIED AND SYNTHESIZED A PROMISING NOVEL CANDIDATE
FOR
USE IN XR-18 DRUG DELIVERY PLATFORM, WHICH IT BELIEVES COULD
OFFER ENHANCED CAPABILITIES COMPARED WITH ITS EXISTING XR-17
TECHNOLOGY
Source text for Eikon: ID:nMFNbjwWny
Further company coverage: OASM.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))